Relmada Therapeutics (RLMD) Earnings Date, Estimates & Call Transcripts → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free RLMD Stock Alerts $3.78 -0.05 (-1.31%) (As of 10:51 AM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateAug. 13EstimatedActual EPS (Mar. 19) -$0.84 Beat By $0.04 Consensus EPS (Mar. 19) -$0.88 Get Relmada Therapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for RLMD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueRLMD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.RLMD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto Swap ProfitsHe Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here Relmada Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.92)($0.92)($0.92)Q2 20241($0.95)($0.95)($0.95)Q3 20241($0.68)($0.68)($0.68)Q4 20241($0.71)($0.71)($0.71)FY 20244($3.26)($3.26)($3.26)RLMD Earnings Date and InformationRelmada Therapeutics last issued its earnings results on March 19th, 2024. The reported ($0.84) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.88) by $0.04. Relmada Therapeutics has generated ($3.28) earnings per share over the last year (($3.28) diluted earnings per share). Earnings for Relmada Therapeutics are expected to grow in the coming year, from ($3.53) to ($2.86) per share. Read More Relmada Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/13/2024Estimated)------- 3/19/2024Q4 2023($0.88)($0.84)+$0.04($0.84)--11/8/2023Q3 2023($0.95)($0.73)+$0.22($0.73)--8/8/2023Q2 2023($0.92)($0.84)+$0.08($0.84)--5/11/2023Q1 2023($0.88)($0.87)+$0.01($0.87)--3/23/2023Q4 2022($1.33)($1.26)+$0.07($1.26)--11/10/2022Q3 2022($1.40)($1.31)+$0.09($1.31)-- Get the Latest News and Ratings for RLMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Relmada Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/11/2022Q2 2022($1.30)($1.33)($0.03)($1.33)-- 5/5/2022Q1 2022($1.21)($1.40)($0.19)($1.40)--3/23/2022Q4 2021($1.60)($1.80)($0.20)($1.80)-- 11/11/2021Q3 2021($1.62)($2.44)($0.82)($2.44)-- 8/10/2021Q2 2021($1.47)($1.56)($0.09)($1.56)-- 5/12/2021Q1 2021($1.38)($1.34)+$0.04($1.34)-- Relmada Therapeutics Earnings - Frequently Asked Questions When did Relmada Therapeutics announce their last quarterly earnings? Relmada Therapeutics (NASDAQ:RLMD) last announced its quarterly earning data on Tuesday, March 19, 2024. Learn more on RLMD's earnings history. Did Relmada Therapeutics beat their earnings estimates last quarter? In the previous quarter, Relmada Therapeutics (NASDAQ:RLMD) reported ($0.84) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.88) by $0.04. Learn more on analysts' earnings estimate vs. RLMD's actual earnings. How much profit does Relmada Therapeutics generate each year? Relmada Therapeutics (NASDAQ:RLMD) has a recorded net income of -$98.79 million. RLMD has generated -$3.28 earnings per share over the last four quarters. What is Relmada Therapeutics's EPS forecast for next year? Relmada Therapeutics's earnings are expected to grow from ($3.53) per share to ($2.86) per share in the next year. More Earnings Resources from MarketBeat Related Companies: CytomX Therapeutics Earnings Date Cyteir Therapeutics Earnings Date Nuvectis Pharma Earnings Date Rezolute Earnings Date Abeona Therapeutics Earnings Date Immunic Earnings Date Repare Therapeutics Earnings Date GlycoMimetics Earnings Date Societal CDMO Earnings Date Citius Pharmaceuticals Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:RLMD) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Relmada Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
